Shareholders' equity · 2011–2025
Heron Therapeutics shareholders' equity
$14.3M+$48.0M · FY2025
Heron Therapeutics (HRTX) reported $14.3M in shareholders' equity for fiscal 2025, +$48.0M from the year before.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $14.3M | +$48.0M | Open → |
| FY20242024-12-31 | −$33.7M | +$322,000 | Open → |
| FY20232023-12-31 | −$34.0M | −$47.5M | Open → |
| FY20222022-12-31 | $13.6M | −82.5% | Open → |
| FY20212021-12-31 | $77.6M | −67.2% | Open → |
| FY20202020-12-31 | $236M | −41.4% | Open → |
| FY20192019-12-31 | $404M | +9.1% | Open → |
| FY20182018-12-31 | $370M | +182.3% | Open → |
| FY20172017-12-31 | $131M | +$152M | Open → |
| FY20162016-12-31 | −$21.3M | −$139M | Open → |
| FY20152015-12-31 | $118M | +87.3% | Open → |
| FY20142014-12-31 | $63.1M | −8.5% | Open → |
| FY20132013-12-31 | $68.9M | +33.1% | Open → |
| FY20122012-12-31 | $51.8M | +229.0% | Open → |
| FY20112011-12-31 | $15.8M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −0.7%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Heron Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/heron-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Heron Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/heron-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-heron-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Heron Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/heron-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-341301 · August 10, 2026
{{cite web |title=Heron Therapeutics shareholders' equity — 10-Q (0001193125-26-341301) |url=https://www.sec.gov/Archives/edgar/data/818033/000119312526341301/hrtx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.